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Summary 
Growth factor-induced stress fiber formation involves 
signal transduction through Rac and Rho proteins and 
production of leukotrienes from arachidonic acid me- 
tabolism. In exploring the relationship between these 
pathways, we found that Rac is essential for EGF- 
induced arachidonic acid production and subsequent 
generation of leukotrienes and that Rac V12, a consti- 
tutively activated mutant of Rac, generates leuko- 
trienes in a growth factor-independent manner. Leu- 
kotrienes generated by EGF or Rac V12 are necessary 
and sufficient for stress fiber formation. Furthermore, 
leukotriene-dependent stress fiber formation requires 
Rho proteins. We have therefore identified elements of 
a pathway from growth factor receptors that includes 
Rac, arachidonic acid production, arachidonic acid 
metabolism to leukotrienes, and leukotriene-depen- 
dent Rho activation. This appears to be the major path- 
way by which Rac influences Rho-dependent cytoskel- 
eton rearrangements. 
Introduction 
The action of growth factors coupled to receptor protein- 
tyrosine kinases often includes the induction of cellular 
migration, which is important in, for instance, wound heal- 
ing, metastasis of tumors, and pattern formation (e.g., Gro- 
tendorst, 1984). These growth factor-induced migratory 
events are brought about by a reorganization of the actin 
cytoskeleton (e.g., Schlessinger and Geiger, 1981) and 
are accompanied by the phosphorylation and reorganiza- 
tion of other cytoskeletal components (e.g., Bretcher, 
1989). The signal transduction pathways leading from 
receptor activation to actin remodeling are still unclear, 
but involve members of the family of Ras-related small 
GTPases. In particular, the Rac and Rho proteins have 
been implicated in growth factor-induced cytoskeletal re- 
organization in Swiss 3T3 cells (Ridley and Hall, 1992; 
Ridley et al., 1992). In these cells, epidermal growth factor 
(EGF) and platelet-derived growth factor first evoke rapid 
actin polymerization at the plasma membrane to produce 
membrane ruffles and lamellipodia, followed by the ap- 
pearance of stress fibers. Microinjection of dominant neg- 
ative Rac proteins (Rac N 17) prior to growth factor addition 
abolishes these effects, while injection of constitutively 
active Rac (Rac V12) is sufficient o induce plasma mem- 
brane-localized actin polymerization and subsequent stress 
fiber formation in the absence of exogeneous factors. 
In addition, stress fiber assembly, but not the membrane 
ruffling, induced either by growth factors or by microinjec- 
tion of Rac V12, is abrogated by C3 transferase. This exo- 
enzyme derived from Clostridium botulinum inactivates 
Rho proteins by ADP-ribosylation of Asp-41 (Aktories et 
al., 1989; Sekine et al., 1989). Furthermore, microinjection 
of quiescent Swiss 3T3 fibroblasts with Rho V14 is suffi- 
cient in itself to produce stress fiber formation (Ridley and 
Hall, 1992). From these data, it can be inferred, at least 
for Swiss 3T3 fibroblasts, that growth factors first activate 
Rac, leading to actin polymerization at the plasma mem- 
brane, and that Rac in turn activates Rho, leading to the 
formation of stress fibers. 
Fetal calf serum (FCS), lysophosphatidic acid (LPA), and 
bombesin also lead to the formation of stress fibers in a 
Rho-dependent manner. However, in contrast with growth 
factor-induced stress fiber assembly, these stimuli act in- 
dependently of Rac. Therefore, at least two different signal 
transduction pathways exist, leading to the stimulation of 
Rho and subsequent stress fiber formation, one Rac de- 
pendent and one Rac independent. 
Apart from Rac and Rho, metabolites of arachidonic acid 
are also implicated in growth factor-induced actin remod- 
eling (Peppelenbosch et al., 1993). In A431 cells, EGF 
provokes a cortical actin polymerization accompanied by 
a breakdown of cytoplasmic actin filaments. Inhibition of 
cyclooxygenase (responsible for the conversion of arachi- 
donic acid to prostaglandins) abolishes the breakdown of 
cytoplasmic actin filaments, whereas inhibition of 5-1ipoxy- 
genase (a key enzyme in the biosynthesis of leukotrienes 
from arachidonic acid) prevents cortical actin polymeriza- 
tion. Finally, cortical actin polymerization can be induced 
by the application of leukotrienes in the absence of added 
growth factors. EGF-induced cytoskeletal reorganization 
involves, therefore, the small GTPases Rac and Rho, as 
well as arachidonic acid metabolites. 
To explore the possible relationship between the action 
of Rac and Rho and arachidonic acid metabolism, we have 
examined EGF-induced actin remodeling in Swiss 3T3 
cells, where the role of Rac and Rho is best understood. 
The results reveal that Rac-induced stress fiber formation 
is abrogated by inhibitors of leukotriene synthesis, whereas 
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Figure 1. Actin Reorganization i Swiss 31"3 
Fibroblasts 
Serum-starved cells, either with no addition (a), 
stimulated for 10 min with EGF (b), stimulated 
with EGF in the presence of NDGA (c), stimu- 
lated for 20 rain with leukotriene C4 (d), stimu- 
lated with LPA (e), or stimulated with LPA in 
the presence of NDGA (f), were fixed and 
stained with rhodamine phalloidin. 
application of leukotrienes is sufficient o activate Rho and 
produce stress fibers. Importantly, EGF-stimulated arachi- 
donic acid release and leukotriene production are blocked 
by expressing dominant negative Rac proteins, while in 
cells expressing a constitutively active Rac protein the 
level of leukotrienes is elevated. Our results show, there- 
fore, that induction of arachidonic acid release and leuko- 
triene production is one of the major biochemical pathways 
by which Rac can influence cytoskeletal architecture. 
Results 
EGF-Induced, but Not LPA-Induced, Stress Fiber 
Formation Requires Lipoxygenase Activity 
To study the possible interactions between arachidonic 
acid metabolism and the small GTPases Rac and Rho 
in controlling EGF-induced actin polymerization, we have 
used Swiss 3T3 fibroblasts, where the action of Rac and 
Rho is well described (Ridley and Hall, 1992; Ridley et al., 
1992). Using rhodamine-labeled phalloidin, we observed 
that serum-starved Swiss 3T3 fibroblasts contain little po- 
lymerized actin (Figure la). Upon addition of EGF (20 ng/ 
ml) to these cells, dramatic changes in actin structure take 
place. Actin polymerization first occurs at the plasma 
membrane (membrane ruffles and lamellipodia), and this 
is followed, somewhat later ( -10  min) by the formation 
of stress fibers (Figure lb). Inhibition of 5-1ipoxygenase, 
by a 10 min preincubation with nordihydroguaretic acid 
(NDGA; 3 p.M), did not influence actin polymerization at 
the plasma membrane, but abolished the EGF-induced 
formation of stress fibers (Figure lc). Also, the stress fiber 
formation induced by platelet-derived growth factor and 
insulin was sensitive to NDGA (data not shown). Similar 
results were obtained using a 10 min preincubation with 
200 nM MK-886 (which inhibits 5-1ipoxygenase-activating 
protein; Gillard et al., 1989; Dixon et al., 1990; Miller et 
al., 1990; data not shown). The results show that lipoxy- 
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Figure 2. Inhibition of Leukotriena E4-1nduced Stress Fiber Forma- 
tion by C3 Transferase 
Swiss 3T3 cells were injected with 100 p,g/ml C3 transferase. Fluores- 
cain complexon was coinjected to facilitate recognition of injected 
cells. Subsequently, cells were treated for 10 rain with leukotriane E4, 
fixed, stained, and investigated with confocal laser scannings micros- 
copy. To the left, the fluorescein image is presented and clearly shows 
the outlines of the C3 transferase-injected cell. To the right, the rhoda- 
mine picture reveals the nature of the actin cytoskeleton ofthe injected 
and uninjected cells. Mock-injected cells did not show alterations in
their cytoskeleton. 
genase is required for growth factor-induced formation of 
stress fibers. 
Independent support for this hypothesis was obtained 
by adding different leukotrienes directly to serum-starved 
cells. The addition of leukotriene E4 (0.8 p,M) produces a 
rapid assembly of parallel stress fibers (maximal effect 
reached in 5 rain; Figure ld), which persist for at least 30 
min. Leukotrienes did not induce any cortical actin poly- 
merization or ruffling. Similar results were obtained with 
leukotriene D4 (0.7 p,M) and with leukotriene C4 (0.5 IIM) 
(data not shown). Inhibition of cyclooxygenase with indo- 
methacin (20 pM; 10 min preincubation) had no effect on 
the EGF-induced actin reorganization in these cells (data 
not shown). From these results we conclude that leuko- 
triene synthesis is required for EGF-induced stress fiber 
assembly, but not for EGF-induced membrane ruffling. 
To obtain further insight into the role of leukotriene syn- 
thesis in stress fiber formation, we studied the effects of 
NDGA and MK-886 on the induction of stress fibers by 
LPA (2.5 p.M). This agonist induces rapid stress fiber for- 
mation in Swiss 3T3 fibroblasts, with a maximal effect after 
10 min (Figure 1 e), without any accompanying cortical ac- 
tin polymerization. Preincubation of the cells with either 
NDGA (10 p.M; 10 min preincubation; Figure l f )  or MK-886 
(200 nM; 10 min preincubation; data not shown) did not 
influence the assembly of new stress fibers provoked by 
LPA. Similar results were obtained for two other stimuli, 
i.e., FCS (10%) and bombesin (10 nM). Therefore, FCS, 
LPA, and bombesin do not require lipoxygenase activity 
in the signal trensduction pathway leading to stress fiber 
formation. 
EGF-induced plasma membrane actin polymerization 
and stress fiber formation are both mediated by Rac in 
Swiss 3T3 cells (Ridley et al., 1992). However, as shown 
above, only the latter is sensitive to lipoxygenase inhibi- 
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Figure 3. Effects of Rac N17 Expression on Leukotriene Synthesis 
(A) Expression of Rac in A14 cells. Lysates of A14 cells, A14 cells 
infected with wild-type VV, and A14 cells infected with Rac N 17 were 
analyzed for Rac N17 expression using Western blotting and a poly- 
clonal Rac antiserum (Diekmann et el., 1991). 
(B and C) Peptidoleukotriene immunoreactivity in Swiss 3T3 cells (B) 
and in A14 cells (C). The graphs how for each bar the averaged results 
from three independent experiments (_+ SEM); each experiment was 
performed in triplicate. 
(D) Mobility shift of the endogenous 42 kDa ERK2 protein upon stimula- 
tion with insulin (5 min) or EGF (5 rain) in VV-Rac N17-infected or 
VV-Ras N17-infected cells analyzed by Western blotting. 
tion. Since both EGF-induced (Rac-dependent) s ress fi- 
ber formation and LPA-induced (Rac-independent) stress 
fiber formation are mediated by Rho (Ridley and Hall, 
1992), but only EGF-induced stress fiber formation re- 
quires lipoxygenase activity, we hypothesized that leuko- 
trienes mediate signaling from Rac to Rho. 
Leukotriene-lnduced Stress Fiber Assembly Is 
Mediated by Rho 
To obtain further insight into the mechanism by which leu- 
kotrienes induce stress fiber formation in Swiss 3T3 fibro- 
blasts, we have investigated whether leukotriene-induced 
stress fiber formation is dependent on Rho, Cells were 
injected with 100 ~tg/ml C3 transferase, which inhibits Rho, 
but not Rac or CDC42 function (Ridley and Hall, 1992; 
Ridley et al., 1992). To identify microinjected cells, we 
coinjected fluorescein complexon (1 mg/ml) with C3 trans- 
ferase. Subsequently, the cells were treated with leuko- 
triene E4 for 10 min. We observed that the leukotriene- 
dependent induction of stress fibers was completely 
inhibited by the C3 transferase (Figure 2), demonstrating 
that leukotriene-induced stress fiber formation requires 
functional Rho protein. 
EGF-Induced Leukotriene Synthesis Is Dependent 
on Functional Rac 
To address whether Rac mediates growth factor-induced 
lipoxygenase metabolism, we have introduced adominant 
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Figure 5. Peptidoleukotriene Synthesis in Rat-1 Cells Constitutively 
Expressing Mutated Rac or Rho Proteins in the Presence or Absence 
of EGF Treatment 
Cells were transfected with the different cDNAs shown, and clones 
were selected. The expression of the transfected genes was estab- 
lished by Western blotting (see Experimental Procedures). The graphs 
represent the mean of 12 individual determinations (± SD) obtained 
in four separate xperiments. 
Figure 4. Actin Reorganization i  Rat-1 Cells Constitutively Express- 
ing Mutated Rac or Rho Proteins 
Cells were fixed and stained with rhodamine phalloidin and subse- 
quently investigated using confocal laserscan microscopy. 
(a) Rat-1 cells expressing Rac N17 protein. 
(b) Rat-1 cells expressing Rac N17 protein stimulated for 10 rain with 
0.5 p.M leukotriene C4. 
(c) Rat-1 cells expressing Rac V12 protein. 
(d) Rat-1 cells expressing Rac V12 protein treated for 30 min with 
NDGA. 
(e) Rat-1 cells expressing Rho V14 protein. 
(f) Rat-1 cells expressing Rho V14 protein treated for 30 rain with 
NDGA. 
negative mutant of Rac, Rac N17 (Ridley et al., 1992), 
into cells using a vaccinia virus (VV) expression system 
previously shown to be a successful way of assessing the 
role of Ras in signal transduction (de Vries-Smits et al., 
1992; Burgering et al., 1993; Medema et al., 1993). Re- 
combinant VV expressing Rac N17 (W-Rac N17) was 
used to infect both Swiss 3T3 and A14 fibroblasts. By 16 
hr postinfection, the cells showed a clear expression of 
the transgene (Figure 3A), in contrast with the cells in- 
fected with wild-type VV. As shown in Figure 3B for Swiss 
3T3 cells and Figure 3C for A14 cells, infection with W-  
Rac N17 inhibited EGF-dependent leukotriene production 
while wild-type VV infection had no effect. To exclude the 
possibility that Rac N17 acts as a dominant negative Ras 
protein, we also analyzed the effect of VV-Rac N17 on the 
phosphorylation of extracellular signal-regulated kinase 
2 (ERK2). In particular, after insulin stimulation of A14 
cells, this process is completely dependent on Ras (de 
Vries-Smits et al., 1992; Burgering et al., 1993). Whereas 
infection with VV-Ras N17 abolished the insulin-induced 
activation of ERK2, expression of Rac N17 had no effect on 
either insulin-induced or EGF-induced activation of ERK2 
(Figure 3D). We concluded that EGF-induced leukotriene 
production requires functional Rac protein. 
Leukotriene Synthesis Is Enhanced by Rac V12 
Expression, but Not by Rho V14 Expression 
If Rac mediates EGF-induced synthesis of leukotrienes, 
constitutive activation of Rac would be expected to induce 
leukotriene synthesis in the absence of growth factors. To 
test this, we introduced a mutant Rac V12 protein into 
Rat-1 fibroblasts by DNA transfection (see Experimental 
Procedures), since Swiss 3T3 are very difficult o transfect. 
Two resulting Rac V12-expressing cell lines show consti- 
tutive ruffling and also show a moderate increase in stress 
fibers that is sensitive to treatment with NDGA (Figures 
4c and 4d). In accordance with this, the two representative 
cell lines had leukotriene levels that were substantially 
higher than in control cells, even after EGF stimulation 
(Figure 5). Addition of EGF did not have an additional effect 
on the high constitutive leukotriene synthesis in Rac V12- 
expressing lines. In contrast, in cells expressing Rac N17, 
EGF-induced ruffling was inhibited (Quiet al., submitted), 
but leukotriene-induced stress fiber formation was not af- 
fected by expressing Rac N 17 (Figures 4a and 4b). A repre- 
sentative Rac N17 cell line did not show elevated leuko- 
triene synthesis, nor did it show an increase in leukotriene 
synthesis upon EGF treatment (Figure 5). In all these cells, 
EGF-induced activation of ERK2 was not affected by the 
mutant Rac proteins, indicating the presence of functional 
EGF receptors (data not shown). These results suggest 
that Rac is required for growth factor-induced leukotriene 
synthesis. 
To assess the role of Rho, if any, in leukotriene synthe- 
sis, we have isolated clones of Rat-1 fibroblasts express- 
ing activated Rho protein (Rho V14). These cell lines have, 
in comparison to the parental cell line, a very high number 
of stress fibers, which are not diminished upon treatment 
with NDGA, providing further evidence for the notion that 
Rho-induced stress fiber formation does not require ara- 
chidonic acid metabolism (Figures 4e and 4f). Expression 
of Rho V14 did not affect significantly the levels of leuko- 
triene synthesis, nor did Rho V14 affect leukotriene pro- 
duction after treatment with EGF (Figure 5). 
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Figure 6. Rac N17 Inhibits Arachidonic Acid Release from Phospho- 
lipids 
(A) Dose-response curve displaying the effect of Naja naja-derived 
PLA2 on peptidoleukotriene synthesis in wild-type VV-infected and 
VV-Rac N17-infected A14 cells. 
(B) Dose-response curve in wild-type VV-infected and VV-Rac N17- 
infected A14 cells, showing peptidoleukotriene synthesis induced by 
application of different concentrations of arachidonic acid. 
(C) EGF-induced arachidonic acid release in A14 cells infected with 
wild-type VV, VV-Rac, or VV-Rac N17. 
(13) Insulin-induced arachidonic acid release in A14 fibroblasts infected 
with either wild-type VV or VV-Rac N17. 
Rac N17 Influences Leukotriene Synthesis by 
Inhibiting Arachidonic Acid Release 
The rate-limiting step in the biosynthesis of leukotrienes 
is the release of arachidonic acid from membrane phos- 
pholipids, Arachidonic acid is subsequently metabolized 
via the different enzymes of the 5-1ipoxygenase pathway 
to produce leukotrienes. To establish whether the effect 
of Rac N17 on leukotriene synthesis is upstream or down- 
stream of arachidonic acid release, we incubated wild-type 
VV-infected or VV-Rac N 17-infected A14 cells with snake 
venom phospholipase A2 (PLA2), Addition of this PLA2 pro- 
vokes leukotriene synthesis in a concentration-dependent 
fashion (Figure 6A). Importantly, there was no difference 
between the wild-type VV-infected and VV-Rac N17- 
infected ceils. Furthermore, leukotriene synthesis induced 
by application of exogeneous arachidonic acid was not 
different in wild-type VV-infected and VV-Rac N17- 
infected cells (Figure 6B). We conclude that the inhibitory 
effect of Rac N 17 expression on EGF-induced leukotriene 
synthesis is upstream of arachidonic acid release. We 
have confirmed this by directly measuring arachidonic 
acid release in wild-type VV-infected, VV-Rac-infected, 
and VV-Rac N17-infected cells. Overexpression of wild- 
type Rac proteins resulted in increased arachidonic acid 
release in response to EGF, whereas expression of the 
Rac N17 protein eliminated the EGF-induced increase in 
arachidonic acid release (Figure 6C). In accordance with 
this, the insulin-induced increase in arachidonic acid re- 
lease is also completely inhibited by Rac N17 (Figure 6D), 
indicating that the involvement of Rac in arachidonic acid 
release is not restricted to EGF. Together these results 
show that functional Rac protein is essential for EGF- and 
insulin-induced release of arachidonic acid from biological 
phospholipids. 
Discussion 
It has previously been shown that in fibroblasts the small 
GTPases Rac and Rho are required sequentially for EGF- 
induced changes in the actin cytoskeleton (Ridley and 
Hall, 1992; Ridley et al., 1992). We have now examined 
the relationship between these two small GTPases and 
arachidonic acid metabolism (Peppelenbosch et al., 1993). 
We first showed that leukotrienes, one of the products of 
arachidonic acid metabolism, are required for some, but 
not all, of the EGF-induced cytoskeletal rearrangements 
in Swiss 3"1"3 cells. In these cells, EGF induces two clear 
cytoskeletal alterations, i.e., a rapid induction of mem- 
brane ruffling and, later, the formation of stress fibers. 
Inhibitors of leukotriene synthesis, i.e., NDGA and MK-886, 
abolished EGF-induced stress fiber formation, but not 
membrane ruffling. Furthermore, addition of leukotrienes 
to serum-starved Swiss 3T3 cells is sufficient for the induc- 
tion of stress fibers. These results are in agreement with 
our earlier eports that leukotriene synthesis is responsible 
for an increase in total actin polymerization of Rat-1 and 
A431 cells (Peppelenbosch et al., 1993). 
Leukotriene-induced stress fiber formation is inhibited 
by microinjection of C3 transferase (Aktories et al., 1989; 
Sekine et al., 1989), indicating that this effect is dependent 
on the Rho GTPase. FCS-, LPA-, and bombesin-induced 
stress fiber formation, which are also Rho dependent (Rid- 
Icy and Hall, 1992), are insensitive to inhibitors of the leu- 
kotriene pathway, showing that these growth factors use 
a different, leukotriene-independent route to activate Rho 
and induce stress fiber formation. Since EGF-induced 
stress fiber formation is dependent on Rac, but FCS-, 
LPA-, and bombesin-induced stress fiber formation is inde- 
pendent of Rac (Ridley et al., 1992), these results point 
to Rac being involved in leukotriene-mediated stress fiber 
formation. This was confirmed through the use of Rac 
N17, which completely inhibited EGF-induced leukotriene 
synthesis in Swiss 3T3, A14, and Rat-1 cell lines, whereas 
expression of wild-type Rac proteins stimulated EGF- 
induced arachidonic acid release (Figure 5) as well as leu- 
kotriene production (data not shown). Moreover, Rat-1 
cells expressing a constitutive active Rac V12 had ele- 
vated levels of leukotrienes, which were largely insensitive 
to EGF-treatment. Finally, N17 Rac was shown to inhibit 
the release of arachidonic acid from phospholipids. To- 
gether, these results show that EGF-induced arachidonic 
acid release and subsequent leukotriene synthesis are 
mediated by the Rac protein and that this signaling path- 
way leads to Rho-dependent stress fiber formation (Fig- 
ure 7). 
Cell 
854 
EGFR 
~'  ' ' ';,'_;~'i ..... ;'ac .......... ~ ' ~  
I cPLA ? 
arachidonic acid 
5-hpoxygenase ~ NDGA 
leukotrienes 
LPA =" rho ,. 
Figure 7. Schematic Representation ofthe Novel Signaling Pathway 
That Leads from the EGF Receptor, via Rac, Arachidonic Acid Re- 
lease, and Leukotriene Synthesis, to Rho-Dependent S ress Fiber For- 
mation 
The details of the Rac-mediated signaling pathway from 
the EGF receptor to arachidonic acid release are not yet 
clear. It has been reported that phosphatidyl inositol-3 ki- 
nase is required upstream from Rac in the regulation of 
cytosketetal rearrangements (Nobes et al., 1995). We 
have shown that EGF-induced leukotriene synthesis is 
sensitive to wortmannin, an inhibitor of phosphatidyl inosi- 
tol-3 kinase (M. P. P. and J. L. B., unpublished data). In 
addition, a number of proteins have been identified that 
may act as guanine nucleotide exchange factors or ef- 
fectors of Rac (reviewed by Hall, 1994; Lamarche and Hall, 
1994), but their role in Rac-mediated signaling and, more 
specifically, in EGF-induced leukotriene synthesis is not 
resolved. Also, the mechanism by which leukotrienes acti- 
vate Rho remains obscure, but it may be that leukotrienes 
directly modulate Rho-controlling enzymes (Tsai et al., 
1989) or that leukotrienes are secreted and subsequently 
activate specific extracellular eceptors (Downey et al., 
1990). 
Activation of cytosolic PLA2 (cPLA2) in response to 
growth factors has been well documented (e.g., Lin et al., 
1992; Spaargaren et al., 1992; Domin and Rozengurt, 
1993; Xu et al., 1994). Therefore, cPLA2 must be regarded 
as a candidate target that could mediate Rac dependent 
arachidonic acid release. This 85 kDa protein is calcium 
dependent (Clark et al., 1991) and needs phosphorylation 
on Ser-505 for full activation. In vitro, this site is phosphory- 
lated by ERK, indicating a possible link with Ras (Lin et 
al., 1993), though the kinase responsible for in vivo phos- 
phorylation has not been established. Rac is known to 
activate a Ser/Thr kinase, p65 P~< (Manser et al., 1994), 
and we are currently trying to address whether cPLA2 is 
a substrate for p65 PAK. Alternatively, cPLA2 may bind di- 
rectly to Rac, although in vitro such an interaction could 
not be demonstated (M. P. P. and A. H., unpublished ata). 
Whether cPLA2 is the sole mediator of growth factor- 
induced arachidonic acid release, however, is still a matter 
of debate, "and other enzymes may be involved as well 
(Goldberg et al., 1994). 
In addition to Rac and Rho, Ras has also been im- 
plicated in arachidonic acid release and cytoskeletal 
changes. Microinjection of constitutive active Ras (Ras 
V12) leads to cytoskeletal remodeling and to arachidonic 
acid release (Bar-Sagi and Feramisco, 1986; Ridley and 
Hall, 1992). In addition, Warner et al. (1993) reported that 
Ras is essential for EGF-induced arachidonic release in 
Rat-1 fibroblasts. This is in apparent contrast with the ob- 
servation that inhibition of Ras does not affect EGF- 
induced actin reorganization in Swiss 3T3 cells (Ridley 
and Hall, 1992). One possible explanation for this apparent 
discrepancy may be that EGF can bypass Ras in the acti- 
vation of downstream events (Burgering et al., 1993). In- 
deed, in Swiss 3T3 cells, neither EGF-induced activation 
of ERK2 nor EGF-induced leukotriene synthesis is abol- 
ished by Ras N17, whereas in A14 cells, both insulin- 
induced activation of ERK2 and insulin-induced leuko- 
triene synthesis is abolished by Ras N17 (Burgering et al., 
1993; M. P. P. and J. L. B, unpublished data). 
In conclusion, we have identified arachidonic acid me- 
tabolism, in particular, the lipoxygenase pathway, as the 
downstream pathway that mediates Rac-induced activa- 
tion of Rho and the subsequent formation of stress fibers. 
In addition, we have established a biochemical signaling 
pathway mediated by Rac, which will greatly facilitate the 
analysis of the mechanism by which this small GTPase 
functions. Finally, since Rac and Rho are involved in cell 
migration and tumor invasiveness (e.g., Habets et al., 
1994), our findings may point to an important function of 
arachidonic acid metabolism in these processes as well. 
Experimental Procedures 
Materials and Cell Culture 
EGF, insulin, NDGA, indomethacin, rhodamine phalloidin, and leuko- 
trienes were obtained from Sigma. [~H]arachidonic a id was pur- 
chased from DuPont-New England Nuclear. MK-886 was a gift of the 
Merck-Frosst Centre for Therapeutic Research. Fluorescein com- 
plexon was obtained from Boehringer Mannheim. 
A14 cells are NIH 3T3 cells expressing the human insulin receptor 
(Burgering et al., 1991). Swiss 3T3, A14, and Rat-1 fibroblasts were 
cultured according to routine procedures in Dulbecco's modified Ea- 
gle's medium (DMEM), supplemented with 10% FCS. For growth factor 
stimulation experiments, Swiss 3T3 cells were serum-starved over- 
night in serum-free medium; all other cell lines were starved in 0.5% 
FCS. 
Rat-1 cells expressing mutant Rac and Rho proteins are described 
elsewhere (Qiu et al., 1995). In brief, a piasmid expressing a tetracyclin- 
controlled transactivator (Gossen and Bujard, 1992) was transfected 
into Rat-1 cells in the presence of a G418 resistance marker, and 
subsequently a construct expressing Rac and Rho mutants controlled 
by a hybrid element containing a tet operator and a cytomegalovirus 
minimal promotor was transfected in the presence of a puromycin 
resistance marker. The presence of the Rac and Rho protein was 
established by Western blotting. The transfected Rat-1 cells were 
grown in DMEM (high glucose) containing 10% FCS, 0.4 mg/ml G418, 
1 p.g/ml puromycin, and 2 i~g/ml tetracyclin. Tetracyclin was withdrawn 
48 hr before xperimentation, which resulted in a 2- to 3-fold increase 
in expression of the transfected genes. The concentration ofFCS was 
reduced to 0.5% 16 hr prior to experimentation. 
Cytochemistry and Microinjection 
After appropriate stimulation, cells were fixed with 2% paraformalde- 
hyde in phosphate-buffered saline (PBS) for 15 min, washed, and per- 
meabilized in 0.1% Triton X-100 containing PBS for 1 min, washed 
and blocked with 0.50/0 bovine serum albumin (BSA) in PBS for 45 
min. After washing, cells were stained with rhodamine phalloidin (100 
ng/ml) and mounted in Moviol. Cells were inspected by confocal laser 
scanning microscopy (Peppelenbosch et al., 1993) or by conventional 
immunofluorescence microscopy. 
Microinjection of the C3 transferase (a gift of D. Diekmann) was 
carried out at 33°C in a buffer containing 140 mM NaCI, 5 mM KCI, 
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2 mM CaCI2, 1 mM MgCI2, 10 mM HEPES, and 10 mM glucose (pH 
7.3) (with NaOH). Fluorescein complexon (1 mg/ml) was coinjected to 
facilitate recognition of injected cells. After injection, cells were stimu- 
lated in the same medium, and cytochemistry was performed as de- 
scribed above. 
VV Infection 
Dominant negative ras and rac cDNAs (Ras N17 and Rac N17) or 
wild-type rac were introduced into a viral growth factor-minus train 
of VV by homologous recombination as described earlier (de Vries- 
Smits et al., 1992; Medema et al., 1993). The authenticity of the viral 
constructs were confirmed by sequence analysis. Wild-type and re- 
combinant virus were grown in RK-13 cells. Swiss 3T3 and A14 cells 
were infected with 10-20 pfu per cell for 60 rain in serum-free medium, 
after which the medium was replaced with either fresh serum-free 
medium (Swiss 3T3 cells) or 0.5% FCS-containing medium (A14 cells). 
Experiments were performed 16-18 hr later. 
Determination of Leukotriene Synthesis 
After appropriate stimulation, leukotrienes were extracted by replacing 
the medium with 2 ml of ethanol. Insoluble matter was spun down at 
15,000 x g for 10 rain, after which the supernatant was evaporated 
under a constant stream of argon. The sample was reconstituted in 
100 p~l of ethanol and again evaporated, and peptidoleukotrienes (a
subset of the leukotriene family) were measured using a commercially 
available immunoassay (Cascade Biochemicals). 
Analysis of ERK2 Phosphorylation 
Cells were scraped into sample buffer, and 50 pg of total protein was 
electrophoresed on a 10% SDS-polyacrylamide gel, blotted to nitro- 
cellulose, and incubated with an antiserum directed against recom- 
binant ERK2. Immune complexes were detected by horseradish per- 
oxidase-conjugated secondary antibody, followed by enhanced 
chemiluminescence (Amersham). 
[aH]Arachidonic Acid Release 
Cells were labeled with [3H]arachidonic acid (180-240 Ci/mmoI; Du- 
Pont-New England Nuclear; 200 i~Ci/106 cells) for 12 hr in 0.5°/0 FCS 
containing DMEM, washed extensively, and stimulated with buffer, 
EGF, or insulin for 1 hr in 0.2% BSA, 0.5% FCS-containing DMEM. 
Subsequently, the medium was collected, and released [3H]arachi- 
donic acid was quantified by liquid scintillation counting. 
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